SCHEMBL1630372

SCHEMBL1630372

CCCC(=O)Nc1ccc(-n2nccc2-c2ccc(O)cc2O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.47
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 7/20 0.44
MAPT P10636 6/20 0.43
HPGD P15428 5/20 0.43
KDM4E B2RXH2 4/20 0.43
GAA P10253 3/20 0.43
NPSR1 Q6W5P4 3/20 0.43
HSD17B10 Q99714 2/20 0.43
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
PTPRC P08575 2/20 0.41
AAK1 Q2M2I8 1/20 0.41
PSMB11 A5LHX3 2/20 0.40
PSMA7 O14818 2/20 0.40
PSMB1 P20618 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1631466 0.91 ALDH1A1 (0.47) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL1628797 0.88 AAK1 (0.43) ALDH1A1KDM4ENPSR1AAK1CNR1
SCHEMBL1629168 0.85 MAPT (0.46) NPC1RAB9AALDH1A1MAPTHPGD
SCHEMBL1630414 0.83 KDM4E (0.51) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL1628783 0.80 ADORA3 (0.53) TP53NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL1629986 0.79 GAA (0.50) RAB9ASMN1; SMN2MAPTKDM4EGAA
SCHEMBL1629510 0.79 TYR (0.48) TP53NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL1628802 0.78 NR3C2 (0.37) ALDH1A1MAPTKDM4EGAANPSR1
SCHEMBL1630287 0.78 KMT2A (0.41) TP53NPC1RAB9AALDH1A1MAPT
SCHEMBL1628955 0.78 MEN1 (0.44) ALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP claimed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US claimed
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P TP53 927/4885NPC1 855/4885RAB9A 2251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.